RAFFA WEALTH MANAGEMENT, LLC’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Other funds holding NTLA
CIC
HWAM
WA
EWM
DADC
BEI
TGIA
WB
RAFFA WEALTH MANAGEMENT, LLC's NTLA Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC held its Intellia Therapeutics (NTLA) position steady in Q2 2026 at 9 shares worth $152. The position accounts for ﹤0.01% of the portfolio, ranked #1306.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in NTLA in Q4 2020 and has held it in 23 quarters since. The position peaked at $5.12K in Q4 2023. 71 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 9 shares of Intellia Therapeutics worth $152 as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC left its Intellia Therapeutics share count unchanged in Q2 2026.
- Intellia Therapeutics made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1306 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in Intellia Therapeutics in Q4 2020 and has held it in 23 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's Intellia Therapeutics position peaked at $5.12K in Q4 2023.
- 71 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.